Direct Activation of Sleep-Promoting VLPO Neurons by Volatile Anesthetics Contributes to Anesthetic Hypnosis  by Moore, Jason T. et al.
Direct Activation of Sleep-PrCurrent Biology 22, 2008–2016, November 6, 2012 ª2012 Elsevier Ltd All rights reserved http://dx.doi.org/10.1016/j.cub.2012.08.042Article
omoting
VLPO Neurons by Volatile Anesthetics
Contributes to Anesthetic HypnosisJason T. Moore,1,2 Jingqiu Chen,2 Bo Han,2
Qing Cheng Meng,2 Sigrid C. Veasey,3,4 Sheryl G. Beck,5
and Max B. Kelz1,2,4,6,*
1Department of Neuroscience
2Department of Anesthesiology and Critical Care
3Division of Sleep Medicine, Department of Medicine
4Center for Sleep and Circadian Neurobiology
5Department of Anesthesiology and Critical Care,
Children’s Hospital of Philadelphia
6Institute for Translational Medicine and Therapeutics
University of Pennsylvania, Philadelphia, PA 19104, USA
Summary
Background: Despite seventeen decades of continuous
clinical use, the neuronal mechanisms through which volatile
anesthetics act to produce unconsciousness remain obscure.
One emerging possibility is that anesthetics exert their
hypnotic effects by hijacking endogenous arousal circuits.
A key sleep-promoting component of this circuitry is the
ventrolateral preoptic nucleus (VLPO), a hypothalamic region
containing both state-independent neurons and neurons that
preferentially fire during natural sleep.
Results: Using c-Fos immunohistochemistry as a biomarker
for antecedent neuronal activity, we show that isoflurane
and halothane increase the number of active neurons in the
VLPO, but only when mice are sedated or unconscious.
Destroying VLPO neurons produces an acute resistance to
isoflurane-induced hypnosis. Electrophysiological studies
prove that the neurons depolarized by isoflurane belong to
the subpopulation of VLPO neurons responsible for promoting
natural sleep, whereas neighboring non-sleep-active VLPO
neurons are unaffected by isoflurane. Finally, we show that
this anesthetic-induced depolarization is not solely due to
a presynaptic inhibition of wake-active neurons as previously
hypothesized but rather is due to a direct postsynaptic effect
on VLPO neurons themselves arising from the closing of
a background potassium conductance.
Conclusions: Cumulatively, this work demonstrates that
anesthetics are capable of directly activating endogenous
sleep-promoting networks and that such actions contribute
to their hypnotic properties.
Introduction
General anesthetics have been used tomanipulate conscious-
ness in patients for nearly 170 years, but it is still not known
how these drugs impart hypnosis. At the molecular level, the
number of possible effector sites is staggering: dozens of
molecules are known to be sensitive to anesthetic agents,
including many types of ion channels (reviewed in [1, 2]),
gap-junction channels [3], and G protein-coupled receptors
[4]. Furthermore, it is clear that there is no single molecular
site of action shared by all anesthetic agents [1]. Thus, the*Correspondence: kelzma@uphs.upenn.eduactions of general anesthetics must be understood in the
context of neural anatomy and network connectivity.
Though anesthetic-induced hypnosis and natural sleep are
distinct states, they share many similarities (reviewed in
[5, 6]), leading to the increasingly popular theory that anes-
thetics may induce hypnosis by acting on endogenous arousal
neural circuitry [7]. Much of the recent research has focused
on anesthetics inhibiting wake-active nuclei such as the
tuberomammillary nucleus [7, 8], but it remains unclear to
what extent sleep-promoting nuclei, such as the ventrolateral
preoptic nucleus (VLPO), are involved in generating the
hypnotic state.
The VLPO is a predominately sleep-active nucleus con-
taining GABAergic and galaninergic neurons that project to
many arousal-promoting nuclei throughout the neuroaxis [9].
Several general anesthetics, including chloral hydrate, pro-
pofol, various barbiturates, dexmedetomidine, and isoflurane,
have been shown to increase the number of active VLPO
neurons [7, 10, 11]. Yet, ablation of VLPO neurons, which
would be predicted to produce resistance to anesthesia, is
known to cause an accrual of sleep debt [12] and has recently
been reported to cause increased sensitivity to isoflurane
anesthesia [13]. Thus, it remains unclear whether VLPO acti-
vation contributes to anesthetic-induced hypnosis or whether
it is a secondary effect unrelated to behavioral state [14].
In the present study, we demonstrate that isoflurane dose-
dependently increases the number of active VLPO neurons,
but not at a subsedative dose or when the animals’ behavioral
state is reversed via pressure reversal. By using whole-cell
recordings in hypothalamic slices, we identify isoflurane-
activated neurons as belonging specifically to the putative
sleep-promoting subpopulation of VLPO neurons. We demon-
strate that isoflurane acts directly on these neurons to reduce
a basal potassium conductance and thereby increase inward
(depolarizing) current. Finally, targeted lesioning of the VLPO
produces an acute resistance to induction by isoflurane. These
results are consistent with anesthetic agents acting on the
endogenous arousal neural circuitry to produce hypnosis
and suggest that the VLPO plays a critical role in anesthetic
induction.
Results
Hypnotic Doses of Isoflurane or Halothane Increase
Expression of c-Fos in a Subset of VLPO Neurons
To determinewhether VLPO neurons are active during volatile-
anesthetic-induced hypnosis, we exposed mice to oxygen
with or without volatile anesthetics for 2 hr, either during the
period of maximal activity following lights-out (‘‘dark phase’’)
or during the period ofmaximal sleep following lights-on (‘‘light
phase’’). Following sacrifice, we analyzed immunohistochem-
ical expression of c-Fos, a marker of antecedent neuronal
activity. Consistent with previous reports [15, 16], and in
contrast to most brain regions [5, 6, 17, 18], the VLPO of non-
anesthetized mice sacrificed during the light phase had a
2.5-fold increase in the number of c-Fos-positive nuclei com-
pared to mice sacrificed during the dark phase (p < 0.001;
Figure 1). Similar increases were also observed for
Figure 1. VLPO c-Fos Immunoreactivity Is Increased Following Exposure to Volatile Anesthetics
(A–F) Sample coronal sections through the hypothalamus showing c-Fos staining (brown nuclei) following a 2 hr exposure to (A) oxygen control, dark phase;
(B) 0.3% isoflurane, dark phase; (C) 0.6% isoflurane, dark phase; (D) 1.2% isoflurane, dark phase; (E) 1.0% isoflurane at 70 atmospheres (atm), light phase; (F)
1.0% halothane, dark phase. Scale bar in (A) represents 50 mm and applies to all panels.
(G) Bar graph summarizing c-Fos expression in VLPO. Counts are per unilateral VLPO in a 10 mm slice. Cell counts were analyzed by ANOVA with post hoc
t tests using the Bonferroni correction for multiple comparisons. Error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001 compared to the nonanesthe-
tized dark-phase control; yyyp < 0.001 compared to 1.2% isoflurane during light phase.
Isoflurane Directly Activates VLPO Neurons
2009sedative and hypnotic levels of isoflurane: 2 hr exposure to
0.6% isoflurane produced an increase of 215% 6 79% (p <
0.001) in c-Fos-positive counts, and 1.2% isoflurane produced
an increase of 179% 6 28% (p < 0.01). To determine the
generalizability among inhaled volatile agents, we tested an
equipotent dose of halothane at 1% [19]. Halothane similarly
increased the number of c-Fos-reactive neurons in VLPO
(150% 6 33%, p < 0.01). There were no significant differences
in c-Fos counts between 0.6% isoflurane, 1.2% isoflurane, and
1.0% halothane (p > 0.05). Conversely, a subsedative dose
of 0.3% isoflurane had no effect (76% 6 50%, p > 0.05). To
determine whether natural sleep and anesthesia have an
additive effect on the number of c-Fos-positive cells in
VLPO, we exposedmice in their light phase to 1.2% isoflurane,
and we found no difference in c-Fos expression compared to
a 1.2% isoflurane dark-phase exposure (decrease of 12% 6
7%, p > 0.05).
To explore the behavioral relevance of VLPO activation
during hypnosis, we used pressure reversal to separate anes-
thetic exposure from hypnosis. Although there are no known
chemical antagonists capable of reversing surgical planes
of anesthesia [20], it has beenwell known for over half a century
that exposing organisms to high external pressures can
reverse the actions of many anesthetics [21–23]. Specifically,
70 atmospheres (atm) is known to decrease isoflurane potency
by more than 50% in mice [22]. After being anesthetized with
1.0% isoflurane at 1 atm for 30 min, the mice were pressurized
to 70 atm with helium gas and remained at pressure for 2 hr,
during which time the mice regained their righting reflex,
as observed through a viewport. Pressure reversal resulted
in an 85% 6 2% reduction in c-Fos-positive neurons in VLPO
compared to mice anesthetized with 1.2% isoflurane at 1 atm
(p < 0.001). Consistent with the behavioral reversal of anes-
thesia, pressure reversal fully reverted levels of c-Fos expres-
sion back to thoseofwakefulness (Figure 1)with nodifferences
among the isoflurane-exposed 70 atm pressure-reversed
group, the 1 atm awake oxygen control group, and the 70
atm pressure-awakened oxygen control group (p > 0.05).Electrophysiological Classification of VLPO Neurons
Forty-nine VLPO neurons were recorded from acutely pre-
pared preoptic hypothalamic slices obtained from 40 anes-
thetic-naive mice. Neurons were classified according to their
response to a bath application of 100 mM norepinephrine
(NA): 15 neurons were strongly depolarized by NA (5.41 6
0.97 mV, p < 0.01) and were classified as NA(+), whereas
34 were hyperpolarized (23.61 6 0.80 mV, p < 0.01) and
were classified as NA(2) (Figure 2). In keeping with previous
literature [24], the majority (79%) of NA(2) neurons had clearly
discernible low-threshold spikes (LTSs) following hyperpolar-
ization (Figure 2B, insert), whereas few NA(+) cells (13%)
exhibited an LTS. The NA(2) LTS VLPO neurons are believed
to be the putative sleep-promoting subset, whereas their
neighboring NA(+) neurons that lack LTS are state indifferent.
Morphological analysis of biocytin-filled neurons revealed
that all NA(+) cells were bipolar, whereas NA(2) cells tended
to be multipolar, as reported previously [24–26]. Basic mem-
brane properties such as membrane resistance and action-
potential characteristics did not differ between these two
neuronal subtypes (Table 1).
Isoflurane Directly Depolarizes NA(2) VLPO Neurons
by Decreasing Potassium Conductance
Two concentrations of isoflurane dissolved in artificial cere-
brospinal fluid (aCSF) were used: 240 mM (roughly equivalent
to 1.2% in oxygen) and 480 mM (roughly equivalent to 2.4%
in oxygen). Neither dose had a significant effect on NA(+)
neurons, though there was a consistent trend toward a reduc-
tion in firing rate (20.46 6 0.28 Hz and 20.76 6 0.54 Hz,
respectively) and membrane potential (21.96 6 1.88 mV
and 22.83 6 3.59 mV, respectively). However, as shown in
Figure 2, exposing NA(2) neurons to 240 mM and 480 mM
isoflurane resulted in a depolarization (+6.36 6 1.20 mV,
p < 0.05; +11.56 6 2.24 mV, p < 0.001) and an increase
in firing rate (+1.29 6 0.29 Hz, p < 0.001; +2.53 6 0.52 Hz,
p < 0.001), nearly tripling or quadrupling their basal firing
rates.
Figure 2. Putative Sleep-Active NA(2) VLPO Neurons Are Depolarized by Ex Vivo Exposure to Isoflurane
(A and B) Sample traces from a NA(+) (A) and a NA(2) (B) VLPO neuron during exposure to norepinephrine (NA) and isoflurane, with insets depicting
membrane responses to hyperpolarizing current injections (2100, 280, and 260 pA). The majority of NA(2) neurons (79%) showed clear evidence of
a rebound low-threshold spike (B, arrowhead in inset), whereas few of the NA(+) neurons (13%) exhibited this phenomenon.
(C) Bar graph depicting change in firing rate relative to baseline.
(D) Bar graph depicting change in membrane potential relative to baseline. Recordings were performed on 15 NA(+) and 34 NA(2) neurons and analyzed by
two-way ANOVAs with post hoc t tests using the Bonferroni correction for multiple comparisons.
Error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001; all comparisons were made against baseline.
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2010To determine whether isofluranewas acting pre- or postsyn-
aptically on NA(2) VLPO neurons, we used two independent
methods to block synaptic transmission: (1) a combination
of the nonselective AMPA and kainate receptor antagonist
6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 mM), the NMDA
receptor antagonist (2R)-amino-5-phosphonopentanoate
(AP5, 100 mM), and the GABAA receptor antagonist bicuculline
(Bic, 20 mM); and (2) aCSF enriched in Mg2+ (9.68 mM) and
depleted in Ca2+ (160 mM) to block synaptic vesicular release.
Both methods were effective at completely abolishing all
postsynaptic events (Figure 3A), but the isoflurane-induced
depolarization and activation of NA(2) VLPO neurons per-
sisted (Figures 3B and 3C). In the presence of DNQX+AP5+Bic,
240 mM isoflurane (n = 7) produced an increase in firing rate
(+1.30 6 0.85 Hz, p < 0.05) and depolarized the resting
membrane potential (+6.23 6 1.63 mV, p < 0.05). In the pres-
ence of high Mg2+ and low Ca2+, 240 mM isoflurane (n = 3)
produced an increase in firing rate (+1.19 6 0.30 Hz, p <
0.05), but the depolarization of the membrane potential was
not significant (+6.47 6 2.83 mV, p > 0.05); 480 mM isoflurane
(n = 3) produced an increase in firing rate (+2.36 6 0.54 Hz,
p < 0.01) and significantly depolarized themembrane potential
(+12.64 6 6.15 mV, p < 0.01).Table 1. Basic Electrophysiological Membrane Properties
RMP (mV) IR (MU) Tau (ms)
NA(+) (n = 15) 257.7 6 2.6 595.8 6 51.6 23.4 6 2.1
NA(2) (n = 34) 256.8 6 1.0 602.8 6 34.0 23.8 6 1.4
Basicmembrane properties did not differ between NA(+) andNA(2) VLPO neuro
IR, internal resistance; AP, action potential.Isoflurane (240 mM) had no effect on the frequency or
amplitude of excitatory or inhibitory postsynaptic currents
(EPSCs and IPSCs) and only altered the kinetics of IPSCs,
with a prolonged half-width (p < 0.05; Figure 4B; see also
Table S1 available online). In contrast, 240 mM isoflurane
produced a pronounced inward current of 12.57 6 2.01 pA
when NA(2) neurons were held at 260 mV (p < 0.001). This
shift was preserved when 240 mM isoflurane was introduced
in the presence of the synaptic inhibitors 20 mM DNQX,
100 mM AP5, and 20 mM Bic, resulting in an inward current of
13.68 6 3.17 pA (p < 0.001) compared to 4.62 6 3.66 pA (p >
0.05, not significant) in the presence of the inhibitors alone
(Figures 4A and 4C).
The isoflurane-induced depolarization observed in NA(2)
neurons was accompanied by an increase in membrane
resistance (+377.5 6 106.4 MU, p < 0.05) in 4 out of 4 neurons
examined (Figures 5A and 5B). To determine whether the
increased resistance and depolarizing inward current were
due to a decreased conductance of chloride or potassium,
the chloride reversal potential was shifted from 275 mV to
215 mV, but this had no effect on the magnitude of the
inward current (data not shown). However, when NA(2)
neurons were held at the reversal potential for potassiumAP Threshold (mV) AP Amplitude (mV) AP Duration (ms)
233.9 6 1.7 52.9 6 2.1 1.6 6 0.1
231.2 6 0.7 49.6 6 2.0 1.7 6 0.1
ns. The following abbreviations are used: RMP, restingmembrane potential;
Figure 3. Activation of NA(2) VLPO Neurons by Isoflurane Persists in the
Presence of Synaptic Blockade
(A) Sample voltage-clamp traces from VLPO neurons inhibited by norepi-
nephrine [NA(2)] show that both excitatory (downward deflections) and
inhibitory (upward deflections) postsynaptic currents were eliminated by
the administration of 20 mM DNQX, 100 mM AP5, and 20 mM bicuculline
(Bic) (n = 7), or by the replacement of normal artificial cerebrospinal fluid
(aCSF) with a mixture in which Ca2+ content was reduced to 160 mM and
Mg2+ content increased to 9.68 mM (n = 3).
(B and C) Isoflurane, at both 240 mM and 480 mM, was effective at increasing
the firing rate (B) and depolarizing the resting membrane potential (C) in
NA(2) neurons, both in normal aCSF and in preparations in which all
postsynaptic activity was abolished. Data were analyzed using two-way
ANOVAs with post hoc t tests using the Bonferroni correction for multiple
comparisons. Error bars represent SEM. n.d., not determined; *p < 0.05;
**p < 0.01; ***p < 0.001; all comparisons were made against baseline.
Isoflurane Directly Activates VLPO Neurons
2011(EK = 2100 mV), the inward current was drastically reduced
(0.65 6 0.52 pA, p < 0.01) and did not differ from 0 pA (p >
0.05; Figure 5C).Lesions of VLPO Neurons Produce Initial Resistance
to Isoflurane-Induced Hypnosis
A targeted galanin-saporin was used to lesion VLPO bilaterally
(n = 15), with an unconjugated saporin used for sham lesions
(n = 7) (Figures 6A–6D). The lesioned group had an average
neuronal loss of 91% 6 2% in VLPO, including the expected
specific loss of galanin neurons (Figure S1). At 6 days and
24 days following surgery, all mice were assessed in parallel
for their sensitivity to isoflurane using a loss of righting reflex
(LORR) paradigm. As depicted in Figure 6E, lesioned mice at
6 days required higher doses of isoflurane to lose their righting
reflex than their sham cohorts did; the effect of the lesion was
a right shift in the LORR dose-response curve, with a shift of
the mean effective dose (ED50) from 0.85% (95% confidence
index [CI]: 0.84%–0.86%) to 0.95% (CI: 0.93%–0.96%)
(Table S2), a dose from which all sham animals had lost their
righting reflex. At 24 days, this effect was reversed in VLPO-
lesioned mice, which then demonstrated a left shift of the
LORR dose-response curve and a significantly decreased
ED50 of 0.78% (CI: 0.75%–0.80%). VLPO lesions produced
no effect on body weight or core body temperature [data
not shown; F(1,37) = 1.292, p > 0.05 and F(1,37) = 0.1810,
p > 0.05, respectively].
Discussion
The putative sleep-active VLPO neurons project extensively
throughout the central nervous system and play a critical
role in arousal regulation. Although most neurons within the
brain are inactivated upon induction of general anesthesia,
herein we demonstrate that the volatile anesthetics can
directly activate putative sleep-promoting VLPO neurons.
VLPO activation occurs in a dose-dependent fashion at
concentrations that precede the onset of anesthetic hypnosis
but does not occur at a low, subsedative dose. Using ex vivo
electrophysiology, we further show that isoflurane only acti-
vates VLPO neurons that are hyperpolarized by NA and exhibit
LTS, both of which are hallmarks of cells whose enhanced
firing is believed to cause the onset andmaintenance of natural
sleep. Consistent with this, our c-Fos studies show no differ-
ence in VLPO c-Fos expression between mice sacrificed
during a period of maximal sleep and anesthetized mice, and
no additivity when anesthesia is delivered during the rest
phase. To strengthen the correlation between anesthetic-
induced activation of VLPO and the onset of behavioral
hypnosis, we further establish that lesioning of the VLPO is
associated with an acute resistance to anesthetic hypnosis.
Conversely, when the anesthetic state is antagonized despite
ongoing exposure to an anesthetic, c-Fos immunoreactivity
in VLPO reverts to awake-like levels, suggesting that the
VLPO may be capable of integrating arousal state inputs and
need not be influenced exclusively by the anesthetic.
VLPO Activation Is a Common Point of Neuronal
Convergence for Many Anesthetics as Well as Sleep
Studies using c-Fos protein immunoreactivity as a marker of
antecedent neuronal activity have demonstrated that propofol
[7], barbiturates [7], dexmedetomidine [10], and chloral
hydrate [11], among others, increase the number of c-Fos-
positive neurons in the VLPO, but whether this translates into
increased neuronal activation has not been shown. In the
current study, we demonstrate that the volatile anesthetic
isoflurane not only increases the expression of c-Fos in VLPO
neurons but also enhances neuronal excitation. Lu et al. [11]
Figure 4. Pre- and Postsynaptic Effects of Iso-
flurane upon NA(2) VLPO Neurons
(A) Sample voltage-clamp traces from a NA(2)
neuron clamped at 260 mV showing an inward
current during isoflurane (ISO) exposure, which
persisted during synaptic blockade.
(B) Average excitatory postsynaptic current
(EPSC, top) and inhibitory postsynaptic current
(IPSC, bottom) traces recorded from a NA(2)
neuron (100 traces averaged). Isoflurane (240 mM)
increased IPSC half-width but had no effect
on frequency or amplitude for either IPSCs or
EPSCs (see Table S1).
(C) Administration of 240 mM isoflurane increased
inwardcurrent inNA(2) cellsheldatafixedvoltage
(260 mV), an effect that persisted during syn-
aptic blockade with 20 mM DNQX, 100 mM AP5,
and 20 mM bicuculline (n = 7). Data were analyzed
using two-way ANOVAs with post hoc t tests
using the Bonferroni correction for multiple com-
parisons. Error bars represent SEM. ***p < 0.001;
all comparisons were made against baseline.
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2012previously demonstrated that isoflurane exposure increases
c-Fos expression in the VLPO, though the anesthetic dose
was not measured. Here, we show that clinically relevant
hypnotic and sedative doses of isoflurane and halothane are
effective at increasing c-Fos in the VLPO, whereas a subseda-
tive dose is not. However, a major drawback to using c-Fos as
an indicator of neuronal activity in VLPO is that the VLPO is not
a homogenous nucleus. The VLPO consists of two very
distinct subpopulations of neurons: two-thirds of the neurons
are characterized as being primarily multipolar, having an
LTS produced by T-type calcium channels and being inhi-
bited by the wake-promoting neurotransmitter NA, and these
are the cells that are believed to be sleep promoting; the
remaining one-third are typically bipolar, do not show LTS,
are excited by NA, and are state indifferent [15, 24, 25]. Aside
from electrophysiological differences, there are currently no
known markers available to distinguish between these two
subpopulations. Therefore, we used ex vivo whole-cell elec-
trophysiology to establish that the NA(2), but not NA(+),
VLPO neurons show increased excitability during exposure
to isoflurane.
Isoflurane had no observable effect on NA(+) neurons: there
was no significant effect on either membrane potential or firing
rate at either isoflurane concentration, demonstrating diver-
gent electrophysiological responses for adjacent NA(+) and
NA(2) neurons. Though there was a trend toward a reduction
in firing rate in NA(+) neurons, a floor effect may have pre-
vented us from observing the full effects of the drug: both
cell types had an average basal firing rate of approximately
1 Hz. Conversely, the putative sleep-active NA(2) neurons
were profoundly affected by isoflurane: both doses were
effective at depolarizing the neurons and increasing the firing
rate. One possible mechanism by which isoflurane could
excite NA(2) VLPO neurons is by acting presynaptically to
increase glutamate release onto VLPO neurons. In single-cell
dissociated neuronal preparations, propofol has been re-
ported to increase glutamate release from presynaptic termi-
nals by acting on presynaptic GABAA receptors, which results
in a depolarization due to a shifted chloride gradient [25].
We found that isoflurane, however, had no effect on glutama-
tergic EPSC frequency (Table S1), ruling out this potential
mechanism. Isoflurane did increase the half-width of GABAA-mediated IPSCs, as has been observed in other neuronal pop-
ulations [27]. However, isoflurane’s potentiation of inhibitory
GABAergic signaling should oppose rather than explain iso-
flurane’s depolarizing effect on NA(2) neurons.
Blocking all synaptic input onto VLPO neurons had little
impact on isoflurane’s effect on NA(2) VLPO neurons’ mem-
brane potential and firing rate. In the presence of antagonists
blocking all presynaptic activity, or in the presence of high
Mg2+ and low Ca2+ to prevent synaptic vesicular release, iso-
flurane still depolarized the NA(2) neurons and produced an
increase in firing rate. Consistent with this, in the absence of
any synaptic blockers, the only significant effect of isoflurane
in voltage-clamp mode (in addition to the aforementioned
increase in GABA IPSC half-width) was an increase in inward
current. These findings demonstrate that isoflurane must
have a direct extrasynaptic effect on NA(2) VLPO neurons.
Although surprising, there is existing evidence for such an
effect: isoflurane, like most volatile anesthetics, is a promis-
cuous drug known to affect a wide range of targets [28]. Of
isoflurane’s known receptor targets, the majority are modu-
lated in a way that would be predicted to lead to an inhibitory
effect, but isoflurane can depolarize cells by potentiating
cation channels [29, 30] or by closing anion channels such as
the tandem pore potassium channels K2P12.1 and K2P13.1
[31] (reviewed in [2, 17, 32]). The latter is a congruent mecha-
nism to explain our isoflurane-induced increase in membrane
resistance, which is accompanied by an inward current that
is abolished at the reversal potential for potassium. Addition-
ally, it should be noted that we cannot exclude a voltage-gated
potassium channel from underlying our effect, because the
cumulative effects of low open probability could be overcome
by abundant channel expression. Hence, although the exact
molecular mechanism through which isoflurane depolarizes
NA(2) VLPO neurons remains presently unknown, isoflurane’s
mechanism is clearly distinct from the disinhibition of VLPO
that is thought to underlie dexmedetomidine’s hypnotic
actions [10].
VLPO Activation Modulates, but Is Not Required for,
Anesthetic Hypnosis
Both natural sleep and anesthetic-induced hypnosis produce
similarly increased numbers of active neurons in VLPO, but
Figure 5. Isoflurane Exposure Increases the Membrane Resistance of
NA(2) VLPO Neurons due to a Reduction in Potassium Conductance
(A) Sample trace from a NA(2) neuron showingmembrane voltage response
to bath administration of 240 mM isoflurane; membrane resistance was
monitored by measuring the magnitude of the downward voltage deflec-
tions in response to 230 pA injected current pulses. Exposure to 240 mM
isoflurane depolarized the NA(2) neuron and increased membrane resis-
tance. This increase in resistance was maintained when negative current
was applied to return the cell to its baseline resting potential in the presence
of isoflurane (data not shown).
(B) Isoflurane significantly increased membrane resistance in all four NA(2)
neurons. The squares are the individual values for the four neurons in the
graph; the horizontal lines represent themean value in each group. *p < 0.05.
(C) Using voltage-clamp techniques, the inward current observed during
isoflurane exposure was diminished when the neurons were held at EK
(2100 mV). The current produced by isoflurane at 2100 mV was not signif-
icantly different from that at 0 pA. Error bars represent SEM. **p < 0.01.
Figure 6. Mice with Targeted VLPO Lesions Become Acutely Resistant to
Isoflurane-Induced Hypnosis
(A–D) 43 DAPI (A and C) and 203 NeuN (B and D) images of a sample sham
(A and B) and lesioned (C and D) animal (see also Figure S1). Lesion efficacy
was assessed via cell counts of NeuN-positive cells; the white boxes in (B)
and (D) are 250 mm tall by 400 mmwide and correspond to the location used
for counting. Two animals out of 17 in the lesion cohort that had less than
80% cell loss in the VLPO compared to shams were excluded from analysis
(n = 7 in the sham group). Average neuronal loss in VLPO for lesioned
animals was 91% 6 2%.
(E) Dose-response curves showing the fraction of unconscious animals as
judged by a loss of righting reflex in response to stepwise increases in
isoflurane concentrations at 6 and 24 days postsurgery; the horizontal
axis is displayed on a logarithmic scale. VLPO lesions produced a significant
rightward shift of the induction dose-response curve at day 6 and a sig-
nificant leftward shift at day 24 (Table S2). Inset: bracketed ED50 values as
calculated by averaging the last concentration at which an animal had an
intact righting reflex with the first concentration at which an animal lost its
righting reflex. Error bars represent SEM. *p < 0.05; ***p < 0.001.
Isoflurane Directly Activates VLPO Neurons
2013there is no additive effect when naturally sleeping mice are
anesthetized with isoflurane. Furthermore, by using pressure
reversal to decouple anesthetic exposure from its behavioralendpoint of hypnosis, our results demonstrate that VLPO
activity correlates with the state of behavioral arousal rather
than with the presence or absence of the anesthetic. There
are no specific antagonists of general anesthesia; however,
other acute interventions including microinjections targeting
the centromedial thalamus as well as systemic administration
of physostigmine, doxapram, and methylphenidate all have
partial efficacy [33–35]. Pressure reversal has been shown to
be effective at a wide range of concentrations for many anes-
thetics [23]. Though isoflurane is capable of directly activating
Current Biology Vol 22 No 21
2014sleep-promoting VLPO neurons, when animals exposed to
hypnotic levels of isoflurane were behaviorally aroused via
pressure reversal, c-Fos counts in VLPO were no different
from those in awake controls, suggesting that the VLPO is
integrating multiple arousal-related inputs.
The VLPO plays a critical role in promoting sleep [9], and
the data presented here argue for a similar role in anesthetic-
induced hypnosis. Yet, it is clear that activation of sleep-
promoting VLPO neurons is not a requirement for sleep—
e.g., eszopiclone-induced sleep does not increase VLPO
c-Fos [36]—or for the onset of anesthetic-induced hypnosis,
as has been demonstrated for ketamine [11]. However, the
sleep-active neurons of the VLPO form one site of conver-
gence entwining the neurobiology of endogenous arousal
state regulation with anesthetic-induced hypnosis. Conse-
quently, the VLPO is a natural candidate for translating the
physiological effects of preexisting sleep deprivation upon
resulting anesthetic hypersensitivity [37, 38].
We used a targeted saporin to lesion galaninergic neurons
within VLPO and an unconjugated saporin as a sham control.
Previous studies lesioned VLPO with ibotenic acid or orexin-
saporin [12, 13] and may have destroyed a different subset of
neurons. However, with a similar loss of >90% of all VLPO
neurons, galanin-saporin treatment produced a short-term
resistance to induction by isoflurane 6 days following the
lesion, resulting in a right shift of the LORR dose-response
curve, shifting the ED50 from 0.85% to 0.95% (Table S2).
This is consistent with a published report showing that
VLPO lesions produce a foreshortened duration of action of
dexmedetomidine [10], but it is in contrast to a report showing
increased burst-suppression ratios—an electroencepha-
lography-dependent measure of anesthetic depth—during
exposure to hypnotic levels of isoflurane due to an accumu-
lation of lesion-produced sleep loss [13]. Because sleep
loss is a known confound of anesthetic sensitivity [37, 38],
our goal was to examine the effects of the lesion before any
significant amount of sleep loss could accrue. Excitotoxic
lesions of the VLPO produce pronounced sleep/wake archi-
tecture changes by 7 days postlesion [12], but targeted sap-
orin lesions have a lag time of 4 days before significant cell
loss is observed [39]. Therefore, we chose 6 days following
saporin lesion to maximize cell loss while minimizing sleep
debt accrual. When we reexamined the mice 18 days later,
the lesion group was more sensitive to induction by isoflur-
ane, with an ED50 of 0.78% compared to 0.85% for the
sham group (Table S2). Although we did not use polysomnog-
raphy to measure sleep and wakefulness in our lesioned
mice, we view our findings as consistent with those of
Eikermann et al. [13]: VLPO lesions produce an acute resis-
tance to isoflurane anesthesia that over time is reversed to
a sensitization due to sleep debt accumulation [12]. Impor-
tantly, despite our best attempts, it is possible that an
accruing sleep debt 6 days following targeted nanoinjection
of galanin-saporin may have minimized a potentially larger-
magnitude shift in anesthetic resistance that could have
resulted from a true acute pharmacologic or genetic inacti-
vation of VLPO. Furthermore, the non-sleep-active NA(+)
neurons are also galaninergic [40] and were thus also suscep-
tible to the galanin-saprorin lesion; we would predict that
lesioning solely the NA(2) VLPO neurons would produce
a larger effect. Based upon preserved temperature and
body weight regulation in our lesioned mice, our small-
volume nanoinjections did not spread to the nearby adjacent
median preoptic area, which participates in thermoregulation[41], or the ventromedial hypothalamus, which contributes to
maintenance of body weight [42].
The relatively small magnitude of the effects of a VLPO
lesion on the ED50 of the LORR curve (12% of sham at
6 days), and the fact that this shift can be reversed if the
animal’s sleep architecture is allowed to be disrupted,
suggests that though it may play an important role, the VLPO
is neither the sole nor the master mediator of anesthetic-
induced hypnosis. But this is not unique to anesthesia:
VLPO-lesioned rats still sleep [12]. Other sleep-promoting
neurons have been discovered in the median preoptic nucleus
[43], basal forebrain [44], and cortex [45]. Hence, it is likely that
despite a VLPO lesion, other sleep-promoting groups remain
intact, as would any hypnotic component arising through the
modulation of activity in these or other state-dependent
neurons.
Conclusion
Although anesthetics are known to increase transcription of
the immediate early gene c-fos in VLPO neurons, it has not
been previously established whether the activation is a conse-
quence of the inhibition of wake-active sites or is indepen-
dently due to actions of the anesthetic agents on VLPO
neurons. Here we have shown that for isoflurane, this activa-
tion is a direct postsynaptic effect resulting from the closure
of a background potassium conductance and is specifically
limited to the presumed sleep-active NA(2) subpopulation of
VLPO neurons. Furthermore, the number of active neurons in
the VLPO, as measured by c-Fos, corresponds to the behav-
ioral state of the animal: mice that are naturally sleeping or
are exposed to hypnotic or sedative levels of a volatile anes-
thetic show relatively high numbers of c-Fos-positive neurons
in the VLPO, whereas mice that are naturally awake or behav-
iorally reversed in the presence of an anesthetic show rela-
tively fewer active neurons in VLPO. Although there is still
much debate as to how general anesthetics mediate hypnosis,
the data presented here are consistent with volatile anes-
thetics acting via the endogenous sleep circuitry. The speci-
ficity with which isoflurane targets solely the sleep-active
subpopulation of neurons in VLPO and the tight coupling
of VLPO activity with behavioral state are suggestive of
a causative, functionally significant relationship between the
activation of VLPO by volatile anesthetics and the onset of
hypnosis.
Experimental Procedures
All studies were carried out in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and approved
by the Institutional Animal Care and Use Committee at the University of
Pennsylvania. Previously described protocols were used for righting-reflex
assessment of anesthetic sensitivity [18, 19, 46] and slice electrophysiology
[47]. Full descriptions of these and other materials and methods are
available in the Supplemental Experimental Procedures.
Supplemental Information
Supplemental Information includes one figure, two tables, and Supple-
mental Experimental Procedures and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2012.08.042.
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